History Lesson

Your article "Nobelists Beat Adversity to Advance Science" (P. Smaglik, The Scientist, Dec. 8, 1997, page 1) should be a renewed lesson in the history of science to individuals responsible for grant evaluations at the National Institutes of Health and the National Science Foundation. The extant peer-review system forces scientists to fit their work and hypotheses into currently accepted paradigms and ignores the fact that scientific discoveries or technological developments during the next gran

Written byNejat nes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your article "Nobelists Beat Adversity to Advance Science" (P. Smaglik, The Scientist, Dec. 8, 1997, page 1) should be a renewed lesson in the history of science to individuals responsible for grant evaluations at the National Institutes of Health and the National Science Foundation. The extant peer-review system forces scientists to fit their work and hypotheses into currently accepted paradigms and ignores the fact that scientific discoveries or technological developments during the next grant period cannot necessarily be predicted and spelled out in a grant application. The "likelihood of success" criterion used to fund grant applications would never hold for groundbreaking scientific work, which by nature may be more likely to fail initially than to succeed.

Funding agencies expect scientists to provide extensive "preliminary" data to consider funding a project. This, however, implies that the basic discoveries have already been made and that the research leading to the discovery was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies